Healing & Recovery

Well Researched

BPC-157 + TB-500

B+T

Combined BPC-157 and TB-500 recovery research blend.

Also known as: Wolverine Stack

Research dose rangeBPC 250–500 mcg + TB 2–5 mg

Route studiedSubcutaneous

Study durationLoading then maintenance, multi-week

Storage2–8 °C reconstituted

Overview

The combined research use of BPC-157 and TB-500, two repair-focused peptides frequently studied together in recovery models.

Key research findings

A popular research combination pairing BPC-157 and TB-500 — the two most-studied repair peptides — to engage complementary pathways: BPC-157's angiogenic/gut-protective actions plus TB-500's actin-driven cell migration. Studied together for broad soft-tissue recovery.

Mechanism of action

Pairs BPC-157's angiogenic and growth-factor signaling with TB-500's actin-regulation and cell-migration activity.

Molecular information

WeightCombination (1,419 + ~4,963 Da)

LengthTwo peptides (15 aa + fragment)

TypeBPC-157 + TB-500 repair combination

Not a single molecule — a co-administered pairing of two distinct repair peptides.

Pharmacokinetics

Peak: ~1–2 hoursHalf-life: Mixed (BPC short; TB longer)Cleared: ~3 days

Peak · 0.1dHalf-life · 0.5d

Illustrative relative-concentration model derived from published pharmacokinetic research. Curve is normalized and provided for educational comparison only — not a dosing schedule.

Research applications

Combined tissue-repair research
Recovery-protocol studies
Connective-tissue investigations

Research protocols

Protocols summarized from published research models. Provided for scientific reference only — not dosing guidance for human use.

Research goalReference amountFrequencyRoute

Loading referenceAmount: BPC 250 mcg 2×/day + TB 2–5 mg 2×/wkFrequency: See componentsRoute: Subcutaneous

Maintenance referenceAmount: BPC 250 mcg/day + TB 2 mg/wkFrequency: See componentsRoute: Subcutaneous

Observed effects timeline

Aggregated observations reported across research literature. Timing and magnitude vary by model and are not a guarantee of outcome.

Week 1–2
Combined repair and angiogenesis signaling reported across the two pathways.
Week 3–6
Soft-tissue recovery changes reported in research contexts.

Research compatibility

Describes how compounds are studied alongside one another in the literature. Not a recommendation to co-administer.

BPC-157

Already a component of this stack.

Avoid combination

TB-500

Already a component of this stack.

Avoid combination

Thymosin Beta-4

TB-500 (a TB4 fragment) is already present.

Use caution

CJC-1295 / Ipamorelin

GH secretagogues complement the Wolverine Stack by increasing endogenous growth hormone, which supports tissue repair processes.

Synergistic

GHK-Cu

Copper peptide promotes collagen synthesis and wound healing through different mechanisms. No negative interactions expected.

Compatible

How to reconstitute

Important

Reconstitute each peptide with bacteriostatic water, swirl gently, and refrigerate. Follow each component's individual handling.

1Allow the vial(s) to reach room temperature (15–20 minutes).
2Swab the stopper with alcohol and let it air dry.
3Add bacteriostatic water slowly down the vial wall.
4Swirl gently until dissolved into a clear solution.
5Refrigerate at 2–8 °C and protect from light.

Open reconstitution calculator

Quality indicators

Uniform white powder

Each lyophilized component should be white to off-white without discoloration.

Clear solution

Each reconstitutes to a clear, colorless, particle-free solution.

Cold-chain integrity

Reconstituted solutions require 2–8 °C storage.

Slight clumping

Small clumps that dissolve completely with gentle swirling are acceptable — shipping can cause minor compaction.

Collapsed or melted appearance

Powder that looks collapsed, melted, or stuck to the vial walls may have been exposed to heat in transit.

Cloudy after reconstitution

Persistent cloudiness, particles, or precipitate after gentle mixing can indicate a degraded or contaminated peptide.

Reported observations & safety

Safety signals reported in the research literature. Compiled for scientific awareness — not medical advice.

Tolerability reflects the individual components; mild injection-site reactions are most commonly reported.
Controlled data on the specific combination as a single product are limited.

References & further reading

Repair peptides BPC-157 and TB-500 (review)

Preclinicalcombinationsoft-tissue repair

Overview of the two repair peptides commonly combined for complementary tissue-healing pathways.

Topics

healingcombinationrecovery

This entry is provided for educational and informational purposes only. It is not medical advice, a dosing protocol, or a claim of therapeutic benefit. Research compounds are supplied strictly for laboratory and research use — not for human or veterinary consumption.

Research level

Well Researched

Substantial peer-reviewed research across multiple models.

Quick reference

Dose rangeBPC 250–500 mcg + TB 2–5 mg

RouteSubcutaneous

DurationLoading then maintenance, multi-week

Storage2–8 °C reconstituted

Half-lifeMixed (BPC short; TB longer)

Catalogue status

This compound is part of our educational reference and is not currently stocked. Browse the catalogue for available research-grade peptides.

Browse catalogue